atezolizumab,cabozantinib
roche,exelixis
['blcsm', 'cabozantinib', 'atezo', 'urothelial']
atezolizumab plus cabozantinib elicits clinical activity in advanced urothelial cancer #asco22 #blcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.